Literature DB >> 4345262

Aspergillosis complicating neoplastic disease.

R D Meyer, L S Young, D Armstrong, B Yu.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4345262     DOI： 10.1016/0002-9343(73)90077-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  74 in total

1.  Respiratory fungus allergy and infection.

Authors:  K M Citron
Journal:  Proc R Soc Med       Date:  1975-09

2.  Cutaneous aspergillosis.

Authors:  L Kumar; R Krishnamurthy; S S Nathan; V Maitreyan; V Shanta
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

3.  Superadded aspergillosis on carcinoid bronchial adenoma leading to delayed diagnosis.

Authors:  L Kumar; M Singh; S K Mitra; C K Bannerjee
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

4.  Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

Authors:  L B Palmer; H E Greenberg; M J Schiff
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

5.  Pulmonary embolism in patients with acute leukemia and severe thrombocytopenia.

Authors:  S W Needleman; M N Stein; J C Hoak
Journal:  West J Med       Date:  1981-07

6.  Fungal colonization in patients with cancer of the upper respiratory tract.

Authors:  V Vidotto; M Clerico; L Franzin; L Lucchini; A Sinicco
Journal:  Mycopathologia       Date:  1986-11       Impact factor: 2.574

7.  Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.

Authors:  V Chazalet; J P Debeaupuis; J Sarfati; J Lortholary; P Ribaud; P Shah; M Cornet; H Vu Thien; E Gluckman; G Brücker; J P Latgé
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 8.  Aspergillus thyroiditis: a review of the literature to highlight clinical challenges.

Authors:  J Nguyen; R Manera; C Minutti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-28       Impact factor: 3.267

9.  Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.

Authors:  E Herreros; C M Martinez; M J Almela; M S Marriott; F G De Las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Unilateral wheeze caused by pseudomembranous aspergillus tracheobronchitis in the immunocompromised patient.

Authors:  R C Tait; B R O'Driscoll; D W Denning
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.